The antifungal treatment market share distribution reflects competitive dynamics among multinational pharmaceutical corporations, specialty pharmaceutical companies, and generic manufacturers competing across various therapeutic segments and geographic markets. Major pharmaceutical companies with established antifungal portfolios maintain significant market presence through branded...